Loading clinical trials...
Loading clinical trials...
This 2 part study will evaluate the safety and efficacy of a combination of Avastin, Tarceva and Xeloda (ATX) as second-line treatment in patients with locally advanced and/or metastatic pancreatic ca...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more
NCT07656571 · Pancreatic Neoplasms, Pancreatic Cancer
NCT07651358 · Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, and more
NCT04048278 · Pancreatic Cancer
NCT05076760 · Solid Tumor, Advanced Cancer, and more
Vienna
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions